Joel Greenblatt - Gotham Asset Management
Holding/activity history for Abcellera Biologics Inc (ABCL)
← All ABCL superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2023 Q3 | 0 | 0.00 | Sell 100.00% | <0.01 | $4.51–8.05 · VW $6.19i | SEC | |
| 2023 Q2 | 46,090 | <0.01 | Reduce 62.61% | 0.01 | $5.53–7.67 · VW $6.86i | $297,741 | SEC |
| 2023 Q1 | 123,264 | 0.02 | Add 6.17% | <0.01 | $7.13–11.38 · VW $9.07i | $929,411 | SEC |
| 2022 Q4 | 116,102 | 0.03 | Add 47.64% | 0.01 | $9.35–14.97 · VW $11.64i | $1,176,113 | SEC |
| 2022 Q3 | 78,638 | 0.02 | Buy | 0.02 | $9.09–14.50 · VW $11.16i | $778,000 | SEC |
| 2022 Q1 | 0 | 0.00 | Sell 100.00% | 0.01 | $7.35–14.79 · VW $9.38i | SEC | |
| 2021 Q4 | 28,415 | 0.01 | Reduce 61.11% | 0.04 | $12.20–17.93 · VW $15.00i | $406,000 | SEC |
| 2021 Q3 | 73,067 | 0.06 | Add 186.67% | 0.04 | $14.51–22.63 · VW $18.39i | $1,464,000 | SEC |
| 2021 Q2 | 25,488 | 0.02 | Buy | 0.02 | $19.80–36.05 · VW $25.69i | $561,000 | SEC |